TxCell Company

TxCell develops cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases.

Founded Date: 2001-01-01
Technology: Anti-infective Drugs
Investor Type: For Profit
Funding Status: M&A
Total Funding: $6.3M
Employee Number: 51-100
Headquarters: Valbonne, Provence-Alpes-Cote d'Azur, France
Investors Number: 1
Last Funding Type: Debt Financing
Estimated Revenue: Less than $1M
Industry: PharmTech